TP53 and acute myeloid leukemia: The frequency of TP53 mutations, and/or chromosome 7 deletions and/or amplifications of genes encoding negative regulators of p53, such as MDM2, is increased at the time of evolution to secondary acute myeloid leukemia (sAML) [35].